Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

Print Me an Organ? Ethical and Regulatory Issues Emerging from 3D Bioprinting in Medicine.

PMID: 28185142 ·

F, r, e, d, e, r, i, c, , G, i, l, b, e, r, t, ;, , C, a, t, h, a, l, , D, , O, ', C, o, n, n, e, l, l, ;, , T, a, j, a, n, k, a, , M, l, a, d, e, n, o, v, s, k, a, ;, , S, u, s, a, n, , D, o, d, d, s

RevistaScience and engineering ethics
Año
PMID28185142

Resumen

Recent developments of three-dimensional printing of biomaterials (3D bioprinting) in medicine have been portrayed as demonstrating the potential to transform some medical treatments, including providing new responses to organ damage or organ failure. However, beyond the hype and before 3D bioprinted organs are ready to be transplanted into humans, several important ethical concerns and regulatory questions need to be addressed. This article starts by raising general ethical concerns associated

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑